Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order

IL27

interleukin 27

Associates with EBI3 to form the IL-27 interleukin, a heterodimeric cytokine which functions in innate immunity. IL-27 has pro- and anti-inflammatory properties, that can regulate T-helper cell development, suppress T-cell proliferation, stimulate cytotoxic T-cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T-helper cells which can differentiate in type 1 effector cells (TH1), type 2 effector cells (TH2) and IL17 producing helper T-cells (TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR which appears to be required but not sufficient for IL-27-mediated signal transduction. IL-27 potentiate the early phase of TH1 response and suppress TH2 and TH17 differentiation. It induces the differentiation of TH1 cells via two distinct pathways, p38 MAPK/TBX21- and ICAM1/ITGAL/ERK-dependent pathways. It also induces STAT1, STAT3, STAT4 and STAT5 phosphorylation and activates TBX21/T-Bet via STAT1 with resulting IL12RB2 up-regulation, an event crucial to TH1 cell commitment. It suppresses the expression of GATA3, the inhibitor TH1 cells development. In CD8 T-cells, it activates STATs as well as GZMB. IL-27 reveals to be a potent inhibitor of TH17 cell development and of IL-17 production. Indeed IL27 alone is also able to inhibit the production of IL17 by CD4 and CD8 T-cells. While IL-27 suppressed the development of proinflammatory Th17 cells via STAT1, it inhibits the development of anti-inflammatory inducible regulatory T-cells, iTreg, independently of STAT1. IL-27 has also an effect on cytokine production, it suppresses proinflammatory cytokine production such as IL2, IL4, IL5 and IL6 and activates suppressors of cytokine signaling such as SOCS1 and SOCS3. Apart from suppression of cytokine production, IL-27 also antagonizes the effects of some cytokines such as IL6 through direct effects on T-cells. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines such as IP-10/CXCL10 and MIG/CXCL9. In vein endothelial cells, it induces IRF1/interferon regulatory factor 1 and increase the expression of MHC class II transactivator/CIITA with resulting up-regulation of major histocompatibility complex class II. IL-27 also demonstrates antiviral activity with inhibitory properties on HIV-1 replication.

Gene Name: interleukin 27
Family/Subfamily: Interleukin
Synonyms: IL27, IL-27, IL-27 p28 subunit, IL30, Interleukin 27, Interleukin-27 subunit alpha, IL27A, Interleukin 30, IL-27-A, IL27p28, IL-27 subunit alpha, IL-27A, IL27-A, p28
Target Sequences: NM_145659 NP_663634.2 Q8NEV9

Publications (2)

1
IL-27 induces the expression of IDO and PD-L1 in human cancer cells. Carbotti G, Barisione G, Airoldi I, Mezzanzanica D, Bagnoli M, Ferrero S, Petretto A, Fabbi M, Ferrini S. Oncotarget. 2015 6:43267-80. (WB; Human) [Full Text Article] [PubMed:26657115] [PMC:PMC4791231] Related Antibodies: LS-B2719.
2
IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation. Morandi F, Di Carlo E, Ferrone S, Petretto A, Pistoia V, Airoldi I. Journal of immunology (Baltimore, Md. : 1950). 2014 Mar;192:2634-42. [Full Text Article] [PubMed:24554774] Related Antibodies: LS-B2719.

☰ Filters
Products
Proteins (14)
Over-Expression Lysate (2)
Recombinant (12)
IL27 (14)
No (14)
6His, C-terminus (1)
GST (1)
GST, N-terminus (1)
His (2)
His, C-Terminal (1)
Human IgG1 Fc (2)
Human Mutant IgG1 Fc (1)
Myc-DDK (Flag) (2)
Human (7)
Mouse (5)
Rat (1)
293T Cells (1)
CHO Cells (4)
E. coli (2)
HEK 293 Cells (3)
Human Cells (1)
Mammalian Cells (1)
Wheat Germ Extract (2)
Purified (5)
Low endotoxin level (7)
Biologically active (5)
IL27 Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
293T Cells
Myc-DDK (Flag)
27.3 kDa
20 µg/$150
Select
CHO Cells
Human Mutant IgG1 Fc
Biologically active
Less than 0.06 EU/µg protein (determined by LAL method).
50 µg/$491
Select
HEK 293 Cells
None
Biologically active
47.8 kDa
10 µg/$349; 2 µg/$268
Select
Mammalian Cells
6His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
49 kDa
10 µg/$339; 50 µg/$633
IL27 Protein - 12.5% SDS-PAGE of human IL27 stained with Coomassie Blue
Select
Wheat Germ Extract
GST
53.9 kDa
10 µg/$479; 25 µg/$670
IL27 Protein - 12.5% SDS-PAGE Stained with Coomassie Blue.
Select
Wheat Germ Extract
GST, N-terminus
10 µg/$479; 25 µg/$670
IL27 Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
HEK 293 Cells
Myc-DDK (Flag)
27.3 kDa
100 µg/$494
Select
CHO Cells
Human IgG1 Fc
Less than 0.06 EU/µg protein (determined by LAL method).
50 µg/$480
Select
CHO Cells
Human IgG1 Fc
Biologically active
Less than 0.06 EU/µg protein (determined by LAL method).
50 µg/$491
Select
Human Cells
His, C-Terminal
Less than 1.0 EU/µg protein (determined by LAL method).
49kD
10 µg/$343; 50 µg/$651; 500 µg/$2,403; 1 mg/$3,431
Select
CHO Cells
None
Biologically active
Less than 0.01 ng/µg (determined by LAL method).
The total predicted molecular weight is 50 kD. The non-reduced and the DTT-reduced proteins migrate as one band at approximately 60 kD by SDS-PAGE.
10 µg/$352; 25 µg/$535
Select
HEK 293 Cells
None
Biologically active
Less than 0.01 ng/µg (determined by LAL method).
The total predicted molecular weight is 49 kD. The non-reduced and the DTT-reduced proteins migrate as one band at approximately 55 kD by SDS-PAGE.
10 µg/$398; 25 µg/$512; 100 µg/$1,363; 500 µg/$4,061
IL27 Protein - Recombinant Interleukin 27 By SDS-PAGE
Select
E. coli
His
24.5 kDa
10 µg/$291; 50 µg/$502; 100 µg/$802; 200 µg/$1,002; 1 mg/$2,144; 500 µg/$1,668; 5 mg/$3,501; 2 mg/$2,334
IL27 Protein - Recombinant Interleukin 27 By SDS-PAGE
Select
E. coli
His
24.8 kDa
10 µg/$289; 50 µg/$492; 100 µg/$785; 200 µg/$982; 1 mg/$2,119; 500 µg/$1,646; 5 mg/$3,431; 2 mg/$2,309
Viewing 1-14 of 14 product results


Filtered By:
Products: Proteins


If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.

PLEASE NOTE

For RESEARCH USE ONLY. Intended for use by laboratory professionals. Not intended for human diagnostic or therapeutic purposes.

The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).